NT5C2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.831800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.476400E-01
Normal-vs-Stage2
5.598800E-01
Normal-vs-Stage3
9.293800E-01
Normal-vs-Stage4
6.892600E-01
Stage1-vs-Stage2
7.468200E-01
Stage1-vs-Stage3
8.167800E-01
Stage1-vs-Stage4
8.995800E-01
Stage2-vs-Stage3
5.916200E-01
Stage2-vs-Stage4
9.054200E-01
Stage3-vs-Stage4
7.987000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.264800E-01
Normal-vs-AfricanAmerican
5.486600E-01
Normal-vs-Asian
2.704200E-01
Caucasian-vs-AfricanAmerican
7.425800E-01
Caucasian-vs-Asian
3.653400E-01
AfricanAmerican-vs-Asian
7.639000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.931600E-01
Normal-vs-Female
5.776600E-01
Male-vs-Female
7.833800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.178800E-01
Normal-vs-Age(41-60Yrs)
3.637600E-01
Normal-vs-Age(61-80Yrs)
7.116400E-01
Normal-vs-Age(81-100Yrs)
8.242800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.760400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.488200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.801600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.680200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.377810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.791600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.047200E-01
Normal-vs-Daily Drinker
6.925600E-01
Normal-vs-Weekly Drinker
6.537200E-01
Normal-vs-Occasional Drinker
1.989020E-01
Normal-vs-Social Drinker
6.607800E-01
Non Drinker-vs-Daily Drinker
9.405400E-01
Non Drinker-vs-Weekly Drinker
9.474800E-01
Non Drinker-vs-Occasional Drinker
1.178780E-01
Non Drinker-vs-Social Drinker
7.510600E-01
Daily Drinker-vs-Weekly Drinker
9.984400E-01
Daily Drinker-vs-Occasional Drinker
1.667410E-01
Daily Drinker-vs-Social Drinker
7.176400E-01
Weekly Drinker-vs-Occasional Drinker
1.766580E-01
Weekly Drinker-vs-Social Drinker
7.310200E-01
Occasional Drinker-vs-Social Drinker
4.939600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.484400E-02
Normal-vs-Grade 2
4.679000E-03
Normal-vs-Grade 3
6.120000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.398300E-02
Grade 1-vs-Grade 3
2.172200E-02
Grade 1-vs-Grade 4
6.484400E-02
Grade 2-vs-Grade 3
3.026600E-01
Grade 2-vs-Grade 4
4.679000E-03
Grade 3-vs-Grade 4
6.120000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.264600E-01
Normal-vs-NonDiabetic
5.672200E-01
Diabetic-vs-NonDiabetic
4.597800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.459160E-01
Normal-vs-NoPancreatitis
6.339200E-01
Pancreatitis-vs-NoPancreatitis
1.283550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.325000E-01
Normal-vs-N1
6.243000E-01
N0-vs-N1
6.216800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.136000E-03
Normal-vs-TP53-NonMutant
3.652200E-01
TP53-Mutant-vs-TP53-NonMutant
5.980800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
